Education
About Us
Working with TipRanks
Follow Us
Balchem Corp. (BCPC)
NASDAQ:BCPC
BCPC Stock Chart & Stats
$152.56
$0.69(0.44%)
At close: 4:00 PM EST
$152.56
$0.69(0.44%)
Day’s Range― - ―
52-Week Range$139.17 - $185.96
Previous CloseN/A
Volume32.16K
Average Volume (3M)174.75K
Market Cap
$4.95B
Enterprise Value$5.00B
Total Cash (Recent Filing)$65.09M
Total Debt (Recent Filing)$155.80M
Price to Earnings (P/E)33.4
Beta0.59
Next Earnings
Feb 13, 2026EPS Estimate
1.18Last Dividend Ex-Date
Dec 26, 2024Dividend Yield0.57%
Share Statistics
EPS (TTM)1.24
Shares Outstanding32,386,260
10 Day Avg. Volume180,692
30 Day Avg. Volume174,755
Financial Highlights & Ratios
PEG Ratio2.35
Price to Book (P/B)4.58
Price to Sales (P/S)5.53
P/FCF Ratio36.01
Enterprise Value/Market Cap1.01
Enterprise Value/Revenue4.93
Enterprise Value/Gross Profit13.77
Enterprise Value/Ebitda19.39
Forecast
1Y Price Target
$190.00Price Target Upside24.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)4.75
Revenue Forecast (FY)$1.02B
Bulls Say, Bears Say
Bulls Say
Capacity ExpansionThe construction of a new state-of-the-art facility is expected to more than double Balchem’s capacity for its fast-growing micro-encapsulation technologies.
EarningsBalchem's revenue and earnings beat expectations, driven by strong sales performance and operational efficiency.
Future Growth PotentialThe Human Nutrition and Health segment significantly outperformed expectations, indicating robust future growth potential.
Bears Say
Balchem News
BCPC FAQ
What was Balchem Corp.’s price range in the past 12 months?
Balchem Corp. lowest stock price was $139.17 and its highest was $185.96 in the past 12 months.
What is Balchem Corp.’s market cap?
Balchem Corp.’s market cap is $4.95B.
When is Balchem Corp.’s upcoming earnings report date?
Balchem Corp.’s upcoming earnings report date is Feb 13, 2026 which is in 97 days.
How were Balchem Corp.’s earnings last quarter?
Balchem Corp. released its earnings results on Oct 21, 2025. The company reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.155 by $0.085.
Is Balchem Corp. overvalued?
According to Wall Street analysts Balchem Corp.’s price is currently Undervalued.
Does Balchem Corp. pay dividends?
Balchem Corp. pays a Annually dividend of $0.87 which represents an annual dividend yield of 0.57%. See more information on Balchem Corp. dividends here
What is Balchem Corp.’s EPS estimate?
Balchem Corp.’s EPS estimate is 1.18.
How many shares outstanding does Balchem Corp. have?
Balchem Corp. has 32,386,260 shares outstanding.
What happened to Balchem Corp.’s price movement after its last earnings report?
Balchem Corp. reported an EPS of $1.24 in its last earnings report, beating expectations of $1.155. Following the earnings report the stock price went up 4.059%.
Which hedge fund is a major shareholder of Balchem Corp.?
Currently, no hedge funds are holding shares in BCPC
Balchem Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$190.00 (24.54% Upside)
$190.00 (24.54% Upside)
Blogger Sentiment
Bullish
BCPC Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 2.8K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.56%
12-Months-Change
Fundamentals
Return on Equity
12.06%
Trailing 12-Months
Asset Growth
4.01%
Trailing 12-Months
Company Description
Balchem Corp.
Balchem Corporation (BCPC) is a global leader in specialty chemicals and nutritional products, primarily serving the food, feed, and pharmaceutical industries. The company operates through three main segments: Nutritional Products, Specialty Products, and Animal Nutrition & Health. Balchem's core offerings include encapsulated nutrients, dairy and meat flavors, and other innovative solutions designed to enhance product performance and safety.
BCPC Company Deck
BCPC Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong financial performance for Balchem Corporation, with record-breaking revenue and growth across all segments. Despite challenges such as increased operating expenses and complex international trade issues, the company continues to demonstrate resilience and strategic growth, particularly in the Human Nutrition and Health and Specialty Products segments.View all BCPC earnings summariesBCPC Stock 12 Month Forecast
Average Price Target
$190.00
▲(24.54% Upside)
Technical Analysis
Ownership Overview
0.58% Insiders
30.53% Mutual Funds
2.42% Other Institutional Investors
40.82% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---